New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor

23Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The treatment of hemophilia A patients with inhibitor could be very expensive. Ankaferd blood stopper (ABS) is a unique folkloric medicinal plant extract, which has historically been used in Turkish traditional medicine as a hemostatic agent. In this article, a 16-year-old boy was presented with uncontrolled bleeding, despite the treatment of factor VIII, rVIIa, factor VIII inhibitor bypass activity (FEIBA), cyclophosphamide, and prednisolone at circumcision site that resolved with ABS in minutes. Our patient with hemophilia A and inhibitor is the first clinical pediatric case. © The Author(s) 2010.

Cite

CITATION STYLE

APA

Öner, A. F., Doǧan, M., Kaya, A., Sal, E., Bektaş, M. S., Yesilmen, O., … Acikgoz, M. (2010). New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor. Clinical and Applied Thrombosis/Hemostasis, 16(6), 705–707. https://doi.org/10.1177/1076029609337313

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free